Multi-functional polymeric nanoparticles for tumour-targeted drug delivery (Q36409038)

14 August 2017

1 reference

title

Multi-functional polymeric nanoparticles for tumour-targeted drug delivery (English)

1 reference

14 August 2017

0 references

1 reference

Lilian E van Vlerken

1

1 reference

14 August 2017

Mansoor M Amiji

series ordinal

2

1 reference

14 August 2017

language of work or name

English

0 references

publication date

1 March 2006

1 reference

Expert Opinion on Drug Delivery

14 August 2017

published in

1 reference

14 August 2017

volume

3

1 reference

14 August 2017

issue

2

1 reference

14 August 2017

page(s)

205-216

1 reference

Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity.

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Biodegradable poly(epsilon -caprolactone) nanoparticles for tumor-targeted delivery of tamoxifen

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Poly(ethylene oxide)-modified poly(beta-amino ester) nanoparticles as a pH-sensitive biodegradable system for paclitaxel delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Long-circulating poly(ethylene glycol)-modified gelatin nanoparticles for intracellular delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Nanoparticle and targeted systems for cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Nanoparticles in cancer therapy and diagnosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Targeting therapeutic and imaging agents to folate receptor positive tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Role of thiamin (vitamin B-1) and transketolase in tumor cell proliferation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Future directions of liposome- and immunoliposome-based cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Design of folic acid-conjugated nanoparticles for drug targeting

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Folate receptor-mediated drug targeting: from therapeutics to diagnostics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Highly specific HER2-mediated cellular uptake of antibody-modified nanoparticles in tumour cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Targeting c-erbB2 and other receptors of the c-erbB family: rationale and clinical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Surface modification of monodisperse magnetite nanoparticles for improved intracellular uptake to breast cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Surface plasmon resonance scattering and absorption of anti-EGFR antibody conjugated gold nanoparticles in cancer diagnostics: applications in oral cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Use of angiogenesis inhibitors in tumour treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

A vascular endothelial growth factor receptor-2 kinase inhibitor potentiates the activity of the conventional chemotherapeutic agents paclitaxel and doxorubicin in tumor xenograft models

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

In vitro procoagulant activity induced in endothelial cells by chemotherapy and antiangiogenic drug combinations: modulation by lower-dose chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Continuous low-dose chemotherapy plus inhibition of cyclooxygenase-2 as an antiangiogenic therapy of glioblastoma multiforme

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Combined analysis of efficacy: the addition of bevacizumab to fluorouracil/leucovorin improves survival for patients with metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Antiangiogenesis drug promising for metastatic colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

A role for survivin in chemoresistance of endothelial cells mediated by VEGF

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Temporal targeting of tumour cells and neovasculature with a nanoscale delivery system

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Mechanisms of multidrug resistance in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Multidrug resistance in cancer: role of ATP-dependent transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

The reversal of multidrug resistance: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Clinical trials of P-glycoprotein reversal in solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Drug delivery to resistant tumors: the potential of poly(alkyl cyanoacrylate) nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Reversion of multidrug resistance by co-encapsulation of doxorubicin and cyclosporin A in polyalkylcyanoacrylate nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Noninvasive detection of clinically occult lymph-node metastases in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Non-invasive detection of apoptosis using magnetic resonance imaging and a targeted contrast agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Methotrexate-modified superparamagnetic nanoparticles and their intracellular uptake into human cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Development of superparamagnetic nanoparticles for MRI: effect of particle size, charge and surface nature on biodistribution

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Iron oxide nanoparticles for sustained delivery of anticancer agents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Antibody-conjugated magnetoliposomes for targeting cancer cells and their application in hyperthermia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Cisplatin, hyperthermia and radiation treatment in human cisplatin-sensitive and resistant glioma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Antitumor effects of combined therapy of recombinant heat shock protein 70 and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Tumor regression by combined immunotherapy and hyperthermia using magnetic nanoparticles in an experimental subcutaneous murine melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Heat-inducible TNF-alpha gene therapy combined with hyperthermia using magnetic nanoparticles as a novel tumor-targeted therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Gold nanocages: bioconjugation and their potential use as optical imaging contrast agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Nanoshell-enabled photonics-based imaging and therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Nanoshell-mediated near-infrared thermal therapy of tumors under magnetic resonance guidance

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Colloidal gold: a novel nanoparticle vector for tumor directed drug delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Antiangiogenic properties of gold nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

The use of gold nanoparticles to enhance radiotherapy in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Boron neutron capture therapy of primary and metastatic brain tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Gadolinium neutron-capture therapy using novel gadopentetic acid-chitosan complex nanoparticles: in vivo growth suppression of experimental melanoma solid tumor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Targeting cells with MR imaging probes based on paramagnetic Gd(III) chelates

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

In vitro cellular accumulation of gadolinium incorporated into chitosan nanoparticles designed for neutron-capture therapy of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

NMR relaxometric investigations of solid lipid nanoparticles (SLN) containing gadolinium(III) complexes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Localized delivery of paclitaxel in solid tumors from biodegradable chitin microparticle formulations

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Comparison of cell uptake, biodistribution and tumor retention of folate-coated and PEG-coated gadolinium nanoparticles in tumor-bearing mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Engineering tumor-targeted gadolinium hexanedione nanoparticles for potential application in neutron capture therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Specific association of thiamine-coated gadolinium nanoparticles with human breast cancer cells expressing thiamine transporters

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

In vivo molecular and cellular imaging with quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Luminescent quantum dots for multiplexed biological detection and imaging

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Tracking metastatic tumor cell extravasation with quantum dot nanocrystals and fluorescence emission-scanning microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Synthesis and characterization of nearly monodisperse CdE (E = sulfur, selenium, tellurium) semiconductor nanocrystallites

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Quantum dot bioconjugates for imaging, labelling and sensing

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Immunofluorescent labeling of cancer marker Her2 and other cellular targets with semiconductor quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

In vivo cancer targeting and imaging with semiconductor quantum dots

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Reversible modulation of quantum dot photoluminescence using a protein- bound photochromic fluorescence resonance energy transfer acceptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Biocompatible fluorescent nanocrystals for immunolabeling of membrane proteins and cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Quantum dots as photosensitizers?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Accelerated discovery of synthetic transfection vectors: parallel synthesis and screening of a degradable polymer library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Parallel Synthesis and Biophysical Characterization of a Degradable Polymer Library for Gene Delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Defective acidification in human breast tumor cells and implications for chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

Immunotargeted nanoshells for integrated cancer imaging and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

In vivoheating of magnetic nanoparticles in alternating magnetic field

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F17425247.3.2.205

21 January 2018

Identifiers

DOI

10.1517/17425247.3.2.205

1 reference

release_g3okv2oemze3laxxithyno7aj4

14 August 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/g3okv2oemze3laxxithyno7aj4

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference